EUVIMEDEUVIMED entdecken
Crossref

Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation

Wayne A Ray iD, Cecilia P Chung, C Michael Stein, Walter Smalley iD, Eli Zimmerman, William D Dupont iD, Adriana M Hung iD, James R Daugherty, Alyson L Dickson, Katherine T Murray

Annals of Internal Medicine · 2023

DOI: 10.7326/m22-3238 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Internal Medicine, 2023. Verfasst von Wayne A Ray und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee (W.A.R., J.R.D.). Hauptthemen laut MEDLINE: Atrial Fibrillation, Amiodarone, Ischemic Stroke, Embolism. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: CSRD VA, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAmiodaroneIschemic StrokeEmbolismStrokeHumansAgedFemaleUnited StatesMaleRivaroxabanFlecainideSotalolAnti-Arrhythmia AgentsRetrospective StudiesMedicareHemorrhageAnticoagulantsHospitalizationDabigatranPyrazolesPyridones

Substanzen

RivaroxabanAmiodaroneFlecainideSotalolAnti-Arrhythmia AgentsAnticoagulantsDabigatranapixabanPyrazolesPyridones

Autor:innen und Institutionen

  • Department of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee (W.A.R., J.R.D.).
  • Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee (C.P.C., A.M.H., A.L.D.).
  • Departments of Medicine and Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee (C.M.S., K.T.M.).
  • Departments of Health Policy and Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee (W.S.).
  • Department of Neurology, Vanderbilt University School of Medicine, Nashville, Tennessee (E.Z.).
  • Departments of Health Policy and Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee (W.D.D.).

ORCID-Profile: Wayne A Ray, Walter Smalley, William D Dupont, Adriana M Hung

Förderung

  • CSRD VA
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Ray, W. A., Chung, C. P., Stein, C. M., Smalley, W., Zimmerman, E., Dupont, W. D., Hung, A. M., Daugherty, J. R., Dickson, A. L., & Murray, K. T. (2023). Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation. Annals of Internal Medicine. https://doi.org/10.7326/m22-3238

Vancouver

Ray WA, Chung CP, Stein CM, Smalley W, Zimmerman E, Dupont WD, et al. Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation. Annals of Internal Medicine. 2023. doi:10.7326/m22-3238

BibTeX
@article{Ray2023,
  author = {Ray, Wayne A and Chung, Cecilia P and Stein, C Michael and Smalley, Walter and Zimmerman, Eli and Dupont, William D and Hung, Adriana M and Daugherty, James R and Dickson, Alyson L and Murray, Katherine T},
  title = {Risk for Bleeding-Related Hospitalizations During Use of Amiodarone With Apixaban or Rivaroxaban in Patients With Atrial Fibrillation},
  journal = {Annals of Internal Medicine},
  year = {2023},
  doi = {10.7326/m22-3238}
}
Kostenlos starten →